Tag Archives: BRX

Analysts’ Perspective: Essent Group (ESNT), Brixmor Property (BRX), AmBev (ABEV)

Essent Group Ltd. (NYSE:ESNT) shares were upgraded by analysts at BTIG Research from Neutral to Buy rating with a price target of $44.

Essent Group Ltd. is a holding company, which engages in the provision of banking services.

*

Brokerage Firm Boenning & Scattergood upgraded Brixmor Property Group Inc. (NYSE:BRX) shares from Neutral to Outperform rating.

Brixmor Property Group, Inc. owns and operates wholly owned portfolio of grocery anchored community and neighborhood shopping centers in the United States.

*

Investment Analysts at Credit Suisse upgraded Ambev SA (NYSE:ABEV) shares from Neutral to Outperform rating.

Ambev SA engages in the production, distribution, and sale of beverages.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/

Analysts’ Perspective: Prologis (PLD), Brixmor Property (BRX), Horizon Pharma (HZNP)

Investment Analysts at Robert W. Baird upgraded Prologis, Inc. (NYSE:PLD) shares from Neutral to Outperform rating with a price target of $55.

Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, management, and leasing of industrial distribution and retail properties.

*

Brokerage Firm Wells Fargo upgraded Brixmor Property Group Inc. (NYSE:BRX) shares from Neutral to Buy rating.

Brixmor Property Group Inc. owns and operates various grocery-anchored community and neighborhood shopping centers in the United States. As of March 31, 2013, the company owned interests in 532 community and neighborhood shopping centers comprising 526 wholly owned community and neighborhood shopping centers; and 6 community and neighborhood shopping centers held through unconsolidated real estate joint ventures.

*

Horizon Pharma plc (NASDAQ:HZNP) shares were upgraded by analysts at Citigroup from Neutral to Buy rating.

Horizon Pharma plc, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. The company’s marketed medicine portfolio consists of ACTIMMUNE for the treatment of chronic granulomatous disease and osteopetrosis; RAVICTI and BUPHENYL/AMMONAPS to treat urea cycle disorders; DUEXIS and VIMOVO for the treatment of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; and PENNSAID for the treatment of pain of osteoarthritis of the knees.

**

Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/